Precision BioSciences, Inc.
DTIL
$4.62
-$0.13-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.11% | 40.98% | 43.62% | 88.35% | 88.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.11% | 40.98% | 43.62% | 88.35% | 88.25% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -11.11% | 40.98% | 43.62% | 88.35% | 88.25% |
| SG&A Expenses | -2.40% | -9.40% | -19.86% | -18.95% | -17.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.40% | 2.59% | -2.08% | 5.72% | -8.13% |
| Operating Income | -27.53% | 40.18% | 60.43% | 83.14% | 50.40% |
| Income Before Tax | -9.99% | 116.85% | 123.66% | 130.31% | 75.05% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.99% | 116.85% | 123.66% | 130.31% | 75.05% |
| Earnings from Discontinued Operations | -- | -- | 88.58% | 103.15% | 72.98% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.54% | 111.69% | 111.73% | 118.98% | 74.50% |
| EBIT | -27.53% | 40.18% | 60.43% | 83.14% | 50.40% |
| EBITDA | -45.06% | 38.36% | 64.20% | 93.91% | 53.87% |
| EPS Basic | 73.88% | 112.00% | 100.41% | 100.95% | 78.06% |
| Normalized Basic EPS | 67.42% | 118.29% | 105.20% | 96.35% | 74.90% |
| EPS Diluted | 73.46% | 111.80% | 100.26% | 100.84% | 78.06% |
| Normalized Diluted EPS | 66.91% | 118.01% | 104.88% | 96.06% | 74.89% |
| Average Basic Shares Outstanding | 90.67% | 79.78% | 53.86% | 32.21% | 23.75% |
| Average Diluted Shares Outstanding | 90.91% | 80.09% | 54.17% | 32.53% | 23.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |